
Reports of three fatal reactions linked to administration of Takeda and Affymax’ Omontys anaemia treatment have led to a recall …
Recruitment drive starts at Aesica, Affymax names a new manufacturing head, plus updates from NeoStem, DPT Labs and HAL Allergy.
The first rival treatment to Amgen’s portfolio of anaemia drugs has been approved in the US.Omontys (peginesatide) has been developed …
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ

